Related Experiment Video
Updated: Aug 20, 2026

Peptide-based Identification of Functional Motifs and their Binding Partners
Published on: June 30, 2013
The neuropathogenesis of AIDS
Francisco González-Scarano1, Julio Martín-García
1Department of Neurology, 3 West Gates, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, Philadelphia 19104-4283, USA. scarano@mail.med.upenn.edu
Insights
HIV-associated dementia (HAD) is a central nervous system complication in HIV-1 patients. Research is ongoing to understand how HIV infection and immune cell activation contribute to neurodegeneration in the brain.
Area of Science:
- Neuroscience
- Infectious Diseases
- Immunology
Background:
- HIV-associated dementia (HAD) is a significant central nervous system complication in HIV-1 infected individuals.
- Highly active antiretroviral therapy has reduced HAD incidence, but milder forms remain a concern.
- Brain macrophages and microglia are key HIV-1 targets in the CNS, implicated in neurodegeneration.
Purpose of the Study:
- To investigate the pathogenesis of neurodegeneration in HIV-associated dementia.
- To determine the roles of HIV-1 infection and immune cell activation in disease progression.
Main Methods:
- Review of current studies on HIV-1 neuropathogenesis.
- Analysis of the contributions of viral infection and monocyte/macrophage activation.
Main Results:
- The exact mechanisms driving neurodegeneration in HAD are still under investigation.
- Studies aim to differentiate the impact of direct viral effects versus immune responses.
Conclusions:
- Understanding the interplay between HIV-1 infection and immune cell activation is crucial for HAD pathogenesis.
- Further research is needed to clarify the precise pathways leading to neurodegeneration in the central nervous system.
Abstract:
HIV-associated dementia (HAD) is an important complication of the central nervous system in patients who are infected with HIV-1. Although the incidence of HAD has markedly decreased since it has become possible to effectively control viral replication in the blood by administering highly active antiretroviral therapy, a less severe form of HAD, comprising a milder cognitive and motor disorder, is now potentially a serious problem. Brain macrophages and microglia are the key cell types that are infected by HIV-1 in the central nervous system, and they are likely to mediate the neurodegeneration seen in patients with HAD; however, the precise pathogenesis of this neurodegeneration is still unclear. Here, we discuss the studies that are being carried out to determine the respective contributions of infection, and monocyte and macrophage activation, to disease progression.
More Related Videos
Related Concept Videos
Diabetic Neuropathy
Inhibitors of Virion Maturation and Assembly
Alzheimer Disease ll: Pathophysiology
Cryptococcal Meningitis
Encephalitis ll: Pathophysiology
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
